Kevin J. Filipski

1.2k total citations
24 papers, 525 citations indexed

About

Kevin J. Filipski is a scholar working on Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kevin J. Filipski has authored 24 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kevin J. Filipski's work include Pancreatic function and diabetes (8 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Kevin J. Filipski is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diabetes Treatment and Management (6 papers) and Metabolism, Diabetes, and Cancer (5 papers). Kevin J. Filipski collaborates with scholars based in United States. Kevin J. Filipski's co-authors include Jeffrey A. Pfefferkorn, Jeffrey T. Kohrt, Jeremy J. Edmunds, John Litchfield, Wayne L. Cody, Christopher F. Bigge, Meihua Tu, Benjamin D. Stevens, Agustin Casimiro‐Garcia and Danette A. Dudley and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Tetrahedron Letters.

In The Last Decade

Kevin J. Filipski

24 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin J. Filipski United States	15	219	185	104	94	54	24	525
Hiroyuki Kakinuma Japan	14	325 1.5×	288 1.6×	160 1.5×	73 0.8×	9 0.2×	43	744
Uwe J. Ries Germany	11	290 1.3×	362 2.0×	82 0.8×	100 1.1×	237 4.4×	17	1.2k
Mary T. Obermeier United States	12	213 1.0×	106 0.6×	233 2.2×	87 0.9×	15 0.3×	19	606
Harilal Patel India	13	202 0.9×	67 0.4×	72 0.7×	49 0.5×	84 1.6×	46	512
David J. St. Jean United States	16	258 1.2×	425 2.3×	113 1.1×	45 0.5×	5 0.1×	28	751
Richard Sulsky United States	12	640 2.9×	203 1.1×	94 0.9×	129 1.4×	7 0.1×	18	1.1k
Shinji Hourai Japan	8	209 1.0×	281 1.5×	97 0.9×	47 0.5×	13 0.2×	11	1.1k
Karen A. Nolan United Kingdom	18	525 2.4×	235 1.3×	16 0.2×	41 0.4×	83 1.5×	28	927
Ellen A. Cannady United States	11	87 0.4×	43 0.2×	88 0.8×	121 1.3×	20 0.4×	21	456
Harold B. Wood United States	19	613 2.8×	271 1.5×	86 0.8×	54 0.6×	12 0.2×	38	950

Countries citing papers authored by Kevin J. Filipski

Since Specialization

Citations

This map shows the geographic impact of Kevin J. Filipski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin J. Filipski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin J. Filipski more than expected).

Fields of papers citing papers by Kevin J. Filipski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin J. Filipski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin J. Filipski. The network helps show where Kevin J. Filipski may publish in the future.

Co-authorship network of co-authors of Kevin J. Filipski

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin J. Filipski. A scholar is included among the top collaborators of Kevin J. Filipski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin J. Filipski. Kevin J. Filipski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Filipski, Kevin J., David J. Edmonds, Michelle R. Garnsey, et al.. (2023). Design of Next-Generation DGAT2 Inhibitor PF-07202954 with Longer Predicted Half-Life. ACS Medicinal Chemistry Letters. 14(10). 1427–1433. 1 indexed citations

Liu, Shenping, Bethany L. Kormos, John D. Knafels, et al.. (2023). Structural studies identify angiotensin II receptor blocker-like compounds as branched-chain ketoacid dehydrogenase kinase inhibitors. Journal of Biological Chemistry. 299(3). 102959–102959. 11 indexed citations

Clerin, Valérie, Hiroshi Saito, Kevin J. Filipski, et al.. (2020). Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion. Journal of Clinical Investigation. 130(12). 6510–6522. 24 indexed citations

Orozco, Christine C., Karen Atkinson, Sangwoo Ryu, et al.. (2019). Structural attributes influencing unbound tissue distribution. European Journal of Medicinal Chemistry. 185. 111813–111813. 21 indexed citations

Filipski, Kevin J., M. F. Sammons, Samit K. Bhattacharya, et al.. (2018). Discovery of Orally Bioavailable Selective Inhibitors of the Sodium-Phosphate Cotransporter NaPi2a (SLC34A1). ACS Medicinal Chemistry Letters. 9(5). 440–445. 24 indexed citations

Filipski, Kevin J.. (2015). Small molecule glucagon receptor antagonists: a patent review (2011 – 2014). Expert Opinion on Therapeutic Patents. 25(7). 819–830. 10 indexed citations

Filipski, Kevin J. & Jeffrey A. Pfefferkorn. (2014). A patent review of glucokinase activators and disruptors of the glucokinase – glucokinase regulatory protein interaction: 2011 – 2014. Expert Opinion on Therapeutic Patents. 24(8). 875–891. 28 indexed citations

Tu, Meihua, Benjamin D. Stevens, Jianwei Bian, et al.. (2014). Identification of a novel conformationally constrained glucagon receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 24(3). 839–844. 16 indexed citations

Filipski, Kevin J., Manthena V. S. Varma, Ayman El‐Kattan, et al.. (2013). Intestinal Targeting of Drugs: Rational Design Approaches and Challenges. Current Topics in Medicinal Chemistry. 13(7). 776–802. 39 indexed citations

10.

Stevens, Benjamin D., John Litchfield, Jeffrey A. Pfefferkorn, et al.. (2013). Discovery of an intravenous hepatoselective glucokinase activator for the treatment of inpatient hyperglycemia. Bioorganic & Medicinal Chemistry Letters. 23(24). 6588–6592. 10 indexed citations

11.

Guzmán-Pérez, Angel, Jeffrey A. Pfefferkorn, Benjamin D. Stevens, et al.. (2013). The design and synthesis of a potent glucagon receptor antagonist with favorable physicochemical and pharmacokinetic properties as a candidate for the treatment of type 2 diabetes mellitus. Bioorganic & Medicinal Chemistry Letters. 23(10). 3051–3058. 35 indexed citations

12.

Filipski, Kevin J., Kentaro Futatsugi, Jeffrey A. Pfefferkorn, & Benjamin D. Stevens. (2012). Glucokinase Activators. Pharmaceutical Patent Analyst. 1(3). 301–311. 14 indexed citations

13.

Filipski, Kevin J., Jianwei Bian, David C. Ebner, et al.. (2011). A novel series of glucagon receptor antagonists with reduced molecular weight and lipophilicity. Bioorganic & Medicinal Chemistry Letters. 22(1). 415–420. 23 indexed citations

14.

Powell, Noel A., Jeffrey T. Kohrt, Kevin J. Filipski, et al.. (2011). Novel and selective spiroindoline-based inhibitors of sky kinase. Bioorganic & Medicinal Chemistry Letters. 22(1). 190–193. 44 indexed citations

15.

Litchfield, John, Raman Sharma, Karen Atkinson, et al.. (2010). Intrinsic electrophilicity of the 4-methylsulfonyl-2-pyridone scaffold in glucokinase activators: Role of glutathione-S-transferases and in vivo quantitation of a glutathione conjugate in rats. Bioorganic & Medicinal Chemistry Letters. 20(21). 6262–6267. 17 indexed citations

16.

Casimiro‐Garcia, Agustin, Christopher F. Bigge, Wayne L. Cody, et al.. (2009). Exploration of 4,4-disubstituted pyrrolidine-1,2-dicarboxamides as potent, orally active Factor Xa inhibitors with extended duration of action. Bioorganic & Medicinal Chemistry. 17(6). 2501–2511. 17 indexed citations

17.

Pfefferkorn, Jeffrey A., Jihong Lou, Martha L. Minich, et al.. (2009). Pyridones as glucokinase activators: Identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle. Bioorganic & Medicinal Chemistry Letters. 19(12). 3247–3252. 66 indexed citations

18.

Larsen, Scott D., Kevin J. Filipski, Jeffrey T. Kohrt, et al.. (2007). Pyrazole inhibitors of HMG-CoA reductase: An attempt to dramatically reduce synthetic complexity through minimal analog re-design. Bioorganic & Medicinal Chemistry Letters. 17(20). 5567–5572. 11 indexed citations

19.

Kohrt, Jeffrey T., Kevin J. Filipski, Wayne L. Cody, et al.. (2005). The discovery of fluoropyridine-based inhibitors of the factor VIIa/TF complex—Part 2. Bioorganic & Medicinal Chemistry Letters. 16(4). 1060–1064. 10 indexed citations

20.

Kohrt, Jeffrey T., Kevin J. Filipski, Stephen T. Rapundalo, Wayne L. Cody, & Jeremy J. Edmunds. (2000). An efficient synthesis of 2-(3-(4-amidinophenylcarbamoyl)naphthalen-2-yl)-5-((2,2-methylpropyl)carbamoyl)benzoic acid: a factor VIIa inhibitor discovered by the Ono Pharmaceutical Company. Tetrahedron Letters. 41(32). 6041–6044. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact